What you missed in glaucoma, dry eye, myopia, and more at CCS 2025
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
CCS 2025: Getting to know the refractive surgery patient population
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
CCS 2025: Taking a contemporary approach to dry eye disease with Dr Mitch Ibach
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
New Opportunities in Topical Glaucoma Management
January 31st 2025A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.